When Transfer Learning Hurts Genetic Risk Prediction

Image for Transfer learning for genomic prediction in underrepresented populations

Learning Outcomes

After studying this material, you should be able to:

  1. Explain why polygenic risk scores (PRSs) perform poorly across populations
  2. Describe how transfer learning applies to genomic prediction
  3. Analyze when cross-population data helps vs. hurts predictive accuracy
  4. Distinguish between conserved and population-specific genetic traits
  5. Compare three modeling strategies for cross-population PRS development
  6. Apply guidelines for choosing the right modeling approach based on sample size and trait type

Step 1: Foundation — What Are Polygenic Risk Scores?

Definition

A Polygenic Risk Score (PRS) is a numerical estimate of an individual's genetic predisposition to a disease or trait, calculated by combining the effects of hundreds to millions of genetic variants (typically single nucleotide polymorphisms, or SNPs).

How It Works

Individual's DNA
        ↓
Identify relevant genetic variants (SNPs)
        ↓
Weight each variant by its effect size
        ↓
Sum all weighted variants
        ↓
= Polygenic Risk Score (PRS)

Real-World Example

For BMI prediction, your PRS might combine 500,000 genetic variants, each contributing a tiny effect, to estimate your genetic tendency toward higher or lower body weight.

Key Metric: SNP Heritability

  • Measures how much of trait variation is explained by measured genetic variants
  • In this study, ranged from 0.07 to 0.28 across eight traits
  • Higher heritability = genetics plays a larger role in that trait

Step 2: The Core Problem — Why PRSs Fail Across Populations

The European Bias Problem

Historically, genome-wide association studies (GWASs) — the research that identifies which genetic variants matter — have been conducted almost exclusively in European populations.

Historical GWAS Data
├── ~80% European populations
├── ~10% Asian populations
└── ~10% All other populations combined

Three Reasons Cross-Population PRSs Fail

ReasonExplanationSimple Analogy
Different genetic architecturesDifferent variants cause the same trait in different populationsDifferent roads leading to the same destination
Population structureGenetic relatedness patterns differ between groupsDifferent family trees
Allele frequency differencesVariants are more/less common across populationsWords that exist in one language but not another

The Practical Barrier

Conducting new, large-scale GWASs from scratch (de novo) across hundreds of thousands of individuals is cost-prohibitive for most healthcare systems.

This creates the central challenge: How do we improve PRS accuracy for underrepresented populations without always starting from scratch?


Step 3: The Proposed Solution — Transfer Learning

What Is Transfer Learning?

Transfer learning means taking knowledge learned from one domain and applying it to a related but different domain.

Transfer Learning in Genomics:

Large European GWAS (source)
         ↓
    Transfer knowledge
         ↓
Small Target Population GWAS (target)
         ↓
    Combined, improved PRS

The Study Setup

This research tested transfer learning between two major biobanks:

BiobankPopulationSize
UK Biobank (UKB)EuropeanHundreds of thousands
Biobank Japan (BBJ)Japanese~200,000 individuals

Eight traits studied:

  • Body Mass Index (BMI)
  • Systolic blood pressure
  • Diastolic blood pressure
  • Red blood cell count
  • White blood cell count
  • HDL cholesterol
  • LDL cholesterol
  • Blood glucose

Performance measured using: Pearson correlation between predicted and actual trait values


Step 4: The Surprising Finding — More Data Isn't Always Better

The Core Discovery

⚠️ Key Insight: Adding European data helps when Japanese sample sizes are small, but actively hurts prediction accuracy once Japanese samples grow large enough.

The Crossover Point

PRS Performance in Japanese Population

High |        ╭──── Japanese-only model
     |       ╱
     |      ╱  ← Crossover (~15,000 samples)
     |     ╱╲
     |    ╱  ╲____ Combined model (European + Japanese)
Low  |___╱
     0    5k   15k   25k   50k   100k
          Japanese Sample Size

What This Means Practically

Japanese Sample SizeBest Strategy
< 5,000 samplesUse European data — provides valuable statistical boost
~15,000 samplesCrossover point — roughly equivalent
> 15,000 samplesJapanese-only data outperforms combined approach

Why Does This Happen?

When European data is included in training:

  • It introduces out-of-distribution noise — genetic patterns that don't apply to Japanese individuals
  • As Japanese data grows, this noise outweighs the statistical benefit of larger sample size
  • The model gets "confused" by conflicting genetic signals from different populations

Step 5: Trait Matters — Conserved vs. Population-Specific Traits

The Concept of Genetic Correlation

Genetic correlation measures how similar the genetic basis of a trait is across two populations.

Genetic Correlation Scale:
0.0 ────────────────────── 1.0
Completely          Identical genetic
different           architecture
(population-        (conserved trait)
specific)

Two Categories of Traits

Category 1: Conserved Traits

(e.g., BMI, blood pressure, blood cell counts)

  • High genetic correlation across populations
  • Similar genetic variants drive the trait in both Europeans and Japanese
  • Benefit from European data up to 25,000–40,000+ Japanese samples
Conserved Trait (e.g., BMI):

Performance
    │                    ╭── Japanese-only
    │                   ╱
    │                  ╱  ← Crossover at ~40k
    │    ╭────────────╱
    │   ╱  Combined model stays competitive longer
    └──────────────────────────
       5k  15k  25k  40k  100k

Category 2: Population-Specific Traits

(e.g., HDL cholesterol, LDL cholesterol, blood glucose)

  • Low genetic correlation across populations
  • Different genetic variants drive the trait in each population
  • European data becomes harmful much sooner (crossover at ~15,000 samples)
  • Optimal European sample size is also smaller
Population-Specific Trait (e.g., HDL):

Performance
    │         ╭── Japanese-only
    │        ╱
    │       ╱  ← Early crossover (~15k)
    │  ╭───╱
    │ ╱  Combined model degrades faster
    └──────────────────────────
       5k  15k  25k  40k  100k

Summary Table

Trait TypeExample TraitsCrossover PointWhy
ConservedBMI, blood pressure25,000–40,000+ samplesShared genetic architecture
Population-specificHDL, LDL, blood glucose~15,000 samplesUnique genetic variants per population

Step 6: Three Modeling Strategies Compared

Strategy 1: European Discovery + Elastic Net

  • Use variants discovered in European GWAS
  • Train elastic net model on those variants
  • Limitation: Misses variants unique to Japanese population

Strategy 2: Cross-Population Meta-Analysis + Elastic Net

  • Run GWAS in both European (UKB) and Japanese (BBJ) populations
  • Combine both sets of results to identify candidate variants
  • Train elastic net on the expanded variant set
UKB European GWAS ──┐
                    ├── Meta-Analysis → Expanded Variants → Elastic Net
BBJ Japanese GWAS ──┘

Best for: Population-specific traits (HDL, LDL, blood glucose) at moderate sample sizes

Strategy 3: PRS-CSx

  • A specialized method that dynamically weights population-specific models
  • Theoretically less sensitive to whether a trait is conserved or population-specific
  • Requires more data to work well

Performance Comparison

Sample SizeBest Strategy
< 10,000 BBJ samplesEuropean discovery + Elastic Net
10,000–25,000 BBJ samplesMeta-analysis (especially for population-specific traits)
> 25,000 BBJ samplesPRS-CSx begins to compete
~100,000 BBJ samplesPRS-CSx matches or exceeds all others (except blood glucose)
Performance Over Time:

High │                              ╭── PRS-CSx
     │              ╭──────────────╯
     │    ╭─────────╯  Meta-analysis
     │────╯  European-only
Low  └────────────────────────────────
     5k   25k   50k   75k   100k
          BBJ Sample Size

Step 7: Practical Decision Framework

When to Use Each Approach

START: What is your target population sample size?
              │
    ┌─────────┴──────────┐
    │                    │
  < 15,000            > 15,000
    │                    │
Use European         Is the trait conserved
data pooling         or population-specific?
                         │
              ┌──────────┴──────────┐
              │                     │
          Conserved           Population-specific
              │                     │
    Continue pooling         Stop pooling European
    European data up         data; use meta-analysis
    to 40k samples           or Japanese-only model

Key Decision Factors

FactorQuestion to AskImpact
Sample sizeHow many target population samples do I have?Determines if transfer learning helps
Trait typeIs the genetic architecture shared across populations?Sets the crossover threshold
Available resourcesCan I run population-specific GWAS?Determines which methods are feasible

Step 8: Broader Implications

What This Research Tells Us

  1. Bigger isn't always better — blindly adding out-of-population data can harm predictions

  2. Know your trait — genetic correlation between populations should guide your modeling strategy

  3. Method selection matters — simple elastic net models can outperform sophisticated methods like PRS-CSx at smaller sample sizes

  4. Diverse biobanks are essential — no amount of transfer learning fully compensates for lack of target-population data

The Path Forward

Current State                    Ideal Future State
─────────────────                ──────────────────
European-dominated GWAS    →     Diverse, global biobanks
One-size-fits-all PRS      →     Population-tailored models
Transfer learning as fix   →     Transfer learning as supplement

Summary: Key Takeaways

ConceptCore Message
PRS cross-population failureEuropean-trained PRSs perform poorly in non-European populations due to genetic architecture differences
Transfer learning benefitHelps when target population data is scarce (< 15,000 samples)
Transfer learning harmDegrades accuracy as target population grows, especially for population-specific traits
Conserved traitsBenefit from European data longer (up to 40,000+ samples)
Population-specific traitsBenefit from European data only at very small sizes
Meta-analysisBest intermediate strategy for population-specific traits
PRS-CSxMost powerful at large sample sizes (> 25,000–100,000)
Core recommendationMatch your modeling strategy to both your sample size AND your trait's genetic architecture

More to study